Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
WRNIP1 | hg19_v2_chr6_+_2765595_2765797 | -0.79 | 2.2e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_29595779 | 19.87 |
ENST00000355973.3
ENST00000377012.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr15_+_89182156 | 13.01 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr6_-_31550192 | 12.59 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr15_+_89182178 | 10.61 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr11_-_60719213 | 8.76 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr15_+_89181974 | 8.60 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr2_+_228678550 | 8.49 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
chr4_-_120549163 | 7.53 |
ENST00000394439.1
ENST00000420633.1 |
PDE5A
|
phosphodiesterase 5A, cGMP-specific |
chr5_-_150466692 | 7.40 |
ENST00000315050.7
ENST00000523338.1 ENST00000522100.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr21_+_27011899 | 6.69 |
ENST00000425221.2
|
JAM2
|
junctional adhesion molecule 2 |
chr4_+_74702214 | 6.68 |
ENST00000226317.5
ENST00000515050.1 |
CXCL6
|
chemokine (C-X-C motif) ligand 6 |
chr19_+_45504688 | 6.43 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
chr3_-_127441406 | 6.27 |
ENST00000487473.1
ENST00000484451.1 |
MGLL
|
monoglyceride lipase |
chr14_+_103592636 | 6.16 |
ENST00000333007.1
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr2_-_203736150 | 5.86 |
ENST00000457524.1
ENST00000421334.1 |
ICA1L
|
islet cell autoantigen 1,69kDa-like |
chr16_+_57673207 | 5.66 |
ENST00000564783.1
ENST00000564729.1 ENST00000565976.1 ENST00000566508.1 ENST00000544297.1 |
GPR56
|
G protein-coupled receptor 56 |
chr20_+_53092123 | 5.49 |
ENST00000262593.5
|
DOK5
|
docking protein 5 |
chr19_-_50400212 | 5.45 |
ENST00000391826.2
|
IL4I1
|
interleukin 4 induced 1 |
chr1_+_212782012 | 5.44 |
ENST00000341491.4
ENST00000366985.1 |
ATF3
|
activating transcription factor 3 |
chr12_-_56236734 | 5.39 |
ENST00000548629.1
|
MMP19
|
matrix metallopeptidase 19 |
chr4_-_76944621 | 5.37 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
chr16_-_11681023 | 5.35 |
ENST00000570904.1
ENST00000574701.1 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr12_-_57522813 | 5.32 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr3_+_105085734 | 5.18 |
ENST00000306107.5
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr17_+_77018896 | 4.99 |
ENST00000578229.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr6_-_32820529 | 4.93 |
ENST00000425148.2
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr6_-_32821599 | 4.91 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr19_+_51152702 | 4.79 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
chr7_+_100547156 | 4.79 |
ENST00000379458.4
|
MUC3A
|
Protein LOC100131514 |
chr12_-_49259643 | 4.77 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
chr6_-_160148356 | 4.76 |
ENST00000401980.3
ENST00000545162.1 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr16_+_57673430 | 4.64 |
ENST00000540164.2
ENST00000568531.1 |
GPR56
|
G protein-coupled receptor 56 |
chr16_+_57406368 | 4.57 |
ENST00000006053.6
ENST00000563383.1 |
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
chr3_+_53195136 | 4.45 |
ENST00000394729.2
ENST00000330452.3 |
PRKCD
|
protein kinase C, delta |
chr3_-_107809816 | 4.43 |
ENST00000361309.5
ENST00000355354.7 |
CD47
|
CD47 molecule |
chr11_-_72432950 | 4.37 |
ENST00000426523.1
ENST00000429686.1 |
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr1_-_153521714 | 4.37 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr11_-_4414880 | 4.36 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr6_+_26383404 | 4.34 |
ENST00000416795.2
ENST00000494184.1 |
BTN2A2
|
butyrophilin, subfamily 2, member A2 |
chr6_-_29527702 | 4.34 |
ENST00000377050.4
|
UBD
|
ubiquitin D |
chr1_-_153521597 | 4.31 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr6_+_32821924 | 4.31 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr15_-_64338521 | 4.27 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
chr16_-_84651673 | 4.17 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr1_-_95007193 | 4.15 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr1_-_169703203 | 4.10 |
ENST00000333360.7
ENST00000367781.4 ENST00000367782.4 ENST00000367780.4 ENST00000367779.4 |
SELE
|
selectin E |
chr20_+_53092232 | 4.01 |
ENST00000395939.1
|
DOK5
|
docking protein 5 |
chr6_+_32812568 | 3.97 |
ENST00000414474.1
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr16_+_66638685 | 3.94 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr3_+_133292759 | 3.91 |
ENST00000431519.2
|
CDV3
|
CDV3 homolog (mouse) |
chr3_+_105086056 | 3.86 |
ENST00000472644.2
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr12_-_57504069 | 3.86 |
ENST00000543873.2
ENST00000554663.1 ENST00000557635.1 |
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr3_+_133292851 | 3.81 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
chr17_+_77021702 | 3.80 |
ENST00000392445.2
ENST00000354124.3 |
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr4_+_103423055 | 3.79 |
ENST00000505458.1
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
chr17_+_32582293 | 3.75 |
ENST00000580907.1
ENST00000225831.4 |
CCL2
|
chemokine (C-C motif) ligand 2 |
chr6_-_160147925 | 3.73 |
ENST00000535561.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
chr11_-_72385437 | 3.71 |
ENST00000418754.2
ENST00000542969.2 ENST00000334456.5 |
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
chr21_+_27011584 | 3.70 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr7_+_55086794 | 3.68 |
ENST00000275493.2
ENST00000442591.1 |
EGFR
|
epidermal growth factor receptor |
chr16_+_57653989 | 3.66 |
ENST00000567835.1
ENST00000569372.1 ENST00000563548.1 ENST00000562003.1 |
GPR56
|
G protein-coupled receptor 56 |
chr17_+_77019030 | 3.60 |
ENST00000580454.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr8_-_141645645 | 3.52 |
ENST00000519980.1
ENST00000220592.5 |
AGO2
|
argonaute RISC catalytic component 2 |
chr1_-_57045228 | 3.47 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr6_+_26383318 | 3.43 |
ENST00000469230.1
ENST00000490025.1 ENST00000356709.4 ENST00000352867.2 ENST00000493275.1 ENST00000472507.1 ENST00000482536.1 ENST00000432533.2 ENST00000482842.1 |
BTN2A2
|
butyrophilin, subfamily 2, member A2 |
chr6_+_14117872 | 3.41 |
ENST00000379153.3
|
CD83
|
CD83 molecule |
chr7_+_65670186 | 3.39 |
ENST00000304842.5
ENST00000442120.1 |
TPST1
|
tyrosylprotein sulfotransferase 1 |
chr1_+_101185290 | 3.38 |
ENST00000370119.4
ENST00000347652.2 ENST00000294728.2 ENST00000370115.1 |
VCAM1
|
vascular cell adhesion molecule 1 |
chr11_-_128392085 | 3.36 |
ENST00000526145.2
ENST00000531611.1 ENST00000319397.6 ENST00000345075.4 ENST00000535549.1 |
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
chr21_-_45660723 | 3.35 |
ENST00000344330.4
ENST00000407780.3 ENST00000400379.3 |
ICOSLG
|
inducible T-cell co-stimulator ligand |
chr3_+_122283064 | 3.35 |
ENST00000296161.4
|
DTX3L
|
deltex 3-like (Drosophila) |
chr16_-_11680791 | 3.33 |
ENST00000571976.1
ENST00000413364.2 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr20_-_44176013 | 3.32 |
ENST00000555685.1
|
EPPIN
|
epididymal peptidase inhibitor |
chr1_-_184943610 | 3.32 |
ENST00000367511.3
|
FAM129A
|
family with sequence similarity 129, member A |
chr11_-_117698765 | 3.30 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
chr21_+_26934165 | 3.29 |
ENST00000456917.1
|
MIR155HG
|
MIR155 host gene (non-protein coding) |
chr6_+_31554962 | 3.28 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
chr3_-_79068594 | 3.27 |
ENST00000436010.2
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr19_-_51893827 | 3.20 |
ENST00000574814.1
|
CTD-2616J11.4
|
chromosome 19 open reading frame 84 |
chr10_+_75670862 | 3.19 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
chr9_-_123691047 | 3.18 |
ENST00000373887.3
|
TRAF1
|
TNF receptor-associated factor 1 |
chr14_+_23846328 | 3.13 |
ENST00000382809.2
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr8_+_54793425 | 3.12 |
ENST00000522225.1
|
RGS20
|
regulator of G-protein signaling 20 |
chr11_-_57194218 | 3.11 |
ENST00000529554.1
|
SLC43A3
|
solute carrier family 43, member 3 |
chr10_+_115439630 | 3.10 |
ENST00000369318.3
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr16_-_84651647 | 3.09 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr16_-_65155833 | 3.08 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr12_+_108908962 | 3.07 |
ENST00000552695.1
ENST00000552758.1 ENST00000361549.2 |
FICD
|
FIC domain containing |
chr7_-_25019760 | 3.06 |
ENST00000352860.1
ENST00000353930.1 ENST00000431825.2 ENST00000313367.2 |
OSBPL3
|
oxysterol binding protein-like 3 |
chr1_+_165864821 | 3.05 |
ENST00000470820.1
|
UCK2
|
uridine-cytidine kinase 2 |
chr8_+_54793454 | 3.05 |
ENST00000276500.4
|
RGS20
|
regulator of G-protein signaling 20 |
chr19_+_56813305 | 3.04 |
ENST00000593151.1
|
AC006116.20
|
Uncharacterized protein |
chr10_-_105615164 | 3.04 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
chr14_+_23846210 | 3.02 |
ENST00000339180.4
ENST00000342473.4 ENST00000397227.3 ENST00000555731.1 |
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr19_+_18284477 | 3.02 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr3_-_158450475 | 3.01 |
ENST00000237696.5
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chrX_+_41192595 | 3.01 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
chr8_+_106330920 | 2.98 |
ENST00000407775.2
|
ZFPM2
|
zinc finger protein, FOG family member 2 |
chr6_+_127898312 | 2.97 |
ENST00000329722.7
|
C6orf58
|
chromosome 6 open reading frame 58 |
chr6_+_126112001 | 2.97 |
ENST00000392477.2
|
NCOA7
|
nuclear receptor coactivator 7 |
chr8_+_17354587 | 2.96 |
ENST00000494857.1
ENST00000522656.1 |
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
chr16_-_11680759 | 2.96 |
ENST00000571459.1
ENST00000570798.1 ENST00000572255.1 ENST00000574763.1 ENST00000574703.1 ENST00000571277.1 ENST00000381810.3 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr12_-_57505121 | 2.95 |
ENST00000538913.2
ENST00000537215.2 ENST00000454075.3 ENST00000554825.1 ENST00000553275.1 ENST00000300134.3 |
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr17_+_77030267 | 2.93 |
ENST00000581774.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr6_-_33282163 | 2.92 |
ENST00000434618.2
ENST00000456592.2 |
TAPBP
|
TAP binding protein (tapasin) |
chr11_-_8832182 | 2.92 |
ENST00000527510.1
ENST00000528527.1 ENST00000528523.1 ENST00000313726.6 |
ST5
|
suppression of tumorigenicity 5 |
chr3_-_98620500 | 2.91 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
chr16_-_67969888 | 2.89 |
ENST00000574576.2
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
chr3_-_122283424 | 2.87 |
ENST00000477522.2
ENST00000360356.2 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr19_+_4229495 | 2.85 |
ENST00000221847.5
|
EBI3
|
Epstein-Barr virus induced 3 |
chr3_+_133292574 | 2.85 |
ENST00000264993.3
|
CDV3
|
CDV3 homolog (mouse) |
chr3_-_122283079 | 2.83 |
ENST00000471785.1
ENST00000466126.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr8_+_17354617 | 2.82 |
ENST00000470360.1
|
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
chr21_-_45660840 | 2.82 |
ENST00000400377.3
|
ICOSLG
|
inducible T-cell co-stimulator ligand |
chr1_-_33336414 | 2.81 |
ENST00000373471.3
ENST00000609187.1 |
FNDC5
|
fibronectin type III domain containing 5 |
chr12_-_77272765 | 2.78 |
ENST00000547435.1
ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2
|
cysteine and glycine-rich protein 2 |
chr2_-_208030647 | 2.78 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr19_+_44084696 | 2.77 |
ENST00000562255.1
ENST00000569031.2 |
PINLYP
|
phospholipase A2 inhibitor and LY6/PLAUR domain containing |
chr11_+_69455855 | 2.76 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr6_+_29691056 | 2.75 |
ENST00000414333.1
ENST00000334668.4 ENST00000259951.7 |
HLA-F
|
major histocompatibility complex, class I, F |
chr1_+_205197304 | 2.75 |
ENST00000358024.3
|
TMCC2
|
transmembrane and coiled-coil domain family 2 |
chr6_-_32806506 | 2.75 |
ENST00000374897.2
ENST00000452392.2 |
TAP2
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Uncharacterized protein |
chr14_+_24630465 | 2.74 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr19_-_55658281 | 2.73 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr5_-_141704566 | 2.72 |
ENST00000344120.4
ENST00000434127.2 |
SPRY4
|
sprouty homolog 4 (Drosophila) |
chr19_-_47735918 | 2.72 |
ENST00000449228.1
ENST00000300880.7 ENST00000341983.4 |
BBC3
|
BCL2 binding component 3 |
chr1_+_169079823 | 2.72 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr6_+_31554826 | 2.69 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chr12_+_121570631 | 2.68 |
ENST00000546057.1
ENST00000377162.2 ENST00000328963.5 ENST00000535250.1 ENST00000541446.1 |
P2RX7
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
chr19_+_57106647 | 2.67 |
ENST00000328070.6
|
ZNF71
|
zinc finger protein 71 |
chr16_-_11681316 | 2.65 |
ENST00000571688.1
|
LITAF
|
lipopolysaccharide-induced TNF factor |
chr19_+_19322758 | 2.62 |
ENST00000252575.6
|
NCAN
|
neurocan |
chr19_-_6690723 | 2.59 |
ENST00000601008.1
|
C3
|
complement component 3 |
chr7_-_98467629 | 2.59 |
ENST00000339375.4
|
TMEM130
|
transmembrane protein 130 |
chr11_+_19799327 | 2.59 |
ENST00000540292.1
|
NAV2
|
neuron navigator 2 |
chr6_+_32811885 | 2.59 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr6_-_10415470 | 2.59 |
ENST00000379604.2
ENST00000379613.3 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr22_+_24990746 | 2.58 |
ENST00000456869.1
ENST00000411974.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chr6_-_11382478 | 2.58 |
ENST00000397378.3
ENST00000513989.1 ENST00000508546.1 ENST00000504387.1 |
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9 |
chr2_+_64681219 | 2.56 |
ENST00000238875.5
|
LGALSL
|
lectin, galactoside-binding-like |
chr12_-_121734489 | 2.56 |
ENST00000412367.2
ENST00000402834.4 ENST00000404169.3 |
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta |
chr10_+_104155450 | 2.55 |
ENST00000471698.1
ENST00000189444.6 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr6_+_31554779 | 2.54 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
chr5_-_121413974 | 2.54 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
chr10_-_49732281 | 2.53 |
ENST00000374170.1
|
ARHGAP22
|
Rho GTPase activating protein 22 |
chr9_-_115095851 | 2.53 |
ENST00000343327.2
|
PTBP3
|
polypyrimidine tract binding protein 3 |
chr8_-_23540402 | 2.52 |
ENST00000523261.1
ENST00000380871.4 |
NKX3-1
|
NK3 homeobox 1 |
chr4_+_74735102 | 2.51 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr16_+_50776021 | 2.51 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr1_+_169075554 | 2.50 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr6_-_33282024 | 2.50 |
ENST00000475304.1
ENST00000489157.1 |
TAPBP
|
TAP binding protein (tapasin) |
chr16_+_57653854 | 2.49 |
ENST00000568908.1
ENST00000568909.1 ENST00000566778.1 ENST00000561988.1 |
GPR56
|
G protein-coupled receptor 56 |
chr16_+_30934376 | 2.48 |
ENST00000562798.1
ENST00000471231.2 |
FBXL19
|
F-box and leucine-rich repeat protein 19 |
chr16_+_50775948 | 2.48 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr6_+_31554456 | 2.47 |
ENST00000339530.4
|
LST1
|
leukocyte specific transcript 1 |
chr2_+_102972363 | 2.46 |
ENST00000409599.1
|
IL18R1
|
interleukin 18 receptor 1 |
chr11_-_57194550 | 2.46 |
ENST00000528187.1
ENST00000524863.1 ENST00000533051.1 ENST00000529494.1 ENST00000395124.1 ENST00000533524.1 ENST00000533245.1 ENST00000530316.1 |
SLC43A3
|
solute carrier family 43, member 3 |
chr7_-_98467543 | 2.45 |
ENST00000345589.4
|
TMEM130
|
transmembrane protein 130 |
chr19_+_10381769 | 2.45 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
chr9_-_123676827 | 2.44 |
ENST00000546084.1
|
TRAF1
|
TNF receptor-associated factor 1 |
chr11_-_57089671 | 2.43 |
ENST00000532437.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr19_+_10197463 | 2.42 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr15_+_73344791 | 2.42 |
ENST00000261908.6
|
NEO1
|
neogenin 1 |
chr14_+_21538517 | 2.41 |
ENST00000298693.3
|
ARHGEF40
|
Rho guanine nucleotide exchange factor (GEF) 40 |
chr8_+_126442563 | 2.41 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr7_-_98467489 | 2.41 |
ENST00000416379.2
|
TMEM130
|
transmembrane protein 130 |
chr3_+_75955817 | 2.40 |
ENST00000487694.3
ENST00000602589.1 |
ROBO2
|
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
chr11_-_102668879 | 2.40 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr6_+_160148593 | 2.40 |
ENST00000337387.4
|
WTAP
|
Wilms tumor 1 associated protein |
chr16_+_86544113 | 2.39 |
ENST00000262426.4
|
FOXF1
|
forkhead box F1 |
chr6_-_44233361 | 2.38 |
ENST00000275015.5
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
chr17_+_47296865 | 2.38 |
ENST00000573347.1
|
ABI3
|
ABI family, member 3 |
chr6_-_30654977 | 2.37 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr12_-_89920030 | 2.36 |
ENST00000413530.1
ENST00000547474.1 |
GALNT4
POC1B-GALNT4
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) POC1B-GALNT4 readthrough |
chr15_+_67430339 | 2.35 |
ENST00000439724.3
|
SMAD3
|
SMAD family member 3 |
chr9_-_118417 | 2.33 |
ENST00000382500.2
|
FOXD4
|
forkhead box D4 |
chr5_+_131593364 | 2.33 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr6_-_37225391 | 2.32 |
ENST00000356757.2
|
TMEM217
|
transmembrane protein 217 |
chr5_-_61031495 | 2.31 |
ENST00000506550.1
ENST00000512882.2 |
CTD-2170G1.2
|
CTD-2170G1.2 |
chr1_+_90287480 | 2.31 |
ENST00000394593.3
|
LRRC8D
|
leucine rich repeat containing 8 family, member D |
chr19_-_51017127 | 2.31 |
ENST00000389208.4
|
ASPDH
|
aspartate dehydrogenase domain containing |
chr6_+_127439749 | 2.30 |
ENST00000356698.4
|
RSPO3
|
R-spondin 3 |
chr2_+_150187020 | 2.30 |
ENST00000334166.4
|
LYPD6
|
LY6/PLAUR domain containing 6 |
chr4_-_74904398 | 2.29 |
ENST00000296026.4
|
CXCL3
|
chemokine (C-X-C motif) ligand 3 |
chr9_-_136344237 | 2.29 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr7_-_108096765 | 2.29 |
ENST00000379024.4
ENST00000351718.4 |
NRCAM
|
neuronal cell adhesion molecule |
chr5_-_35938674 | 2.28 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
chr12_+_54519842 | 2.28 |
ENST00000508564.1
|
RP11-834C11.4
|
RP11-834C11.4 |
chr1_+_227058264 | 2.27 |
ENST00000366783.3
ENST00000340188.4 ENST00000495488.1 ENST00000422240.2 |
PSEN2
|
presenilin 2 (Alzheimer disease 4) |
chr6_-_37225367 | 2.27 |
ENST00000336655.2
|
TMEM217
|
transmembrane protein 217 |
chr6_+_116692102 | 2.27 |
ENST00000359564.2
|
DSE
|
dermatan sulfate epimerase |
chr17_+_36861735 | 2.26 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
chr9_-_95896550 | 2.26 |
ENST00000375446.4
|
NINJ1
|
ninjurin 1 |
chr14_-_24020858 | 2.25 |
ENST00000419474.3
|
ZFHX2
|
zinc finger homeobox 2 |
chr6_-_10415218 | 2.24 |
ENST00000466073.1
ENST00000498450.1 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr8_+_31497271 | 2.24 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
chr16_-_65155979 | 2.23 |
ENST00000562325.1
ENST00000268603.4 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr3_-_158450231 | 2.23 |
ENST00000479756.1
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chr9_-_136344197 | 2.22 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr11_+_19798964 | 2.22 |
ENST00000527559.2
|
NAV2
|
neuron navigator 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 32.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
3.1 | 12.4 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
3.0 | 11.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
2.8 | 11.3 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
2.8 | 8.3 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
2.6 | 7.9 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
2.3 | 6.9 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
2.2 | 8.7 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
2.2 | 6.5 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
2.2 | 17.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.0 | 7.9 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
1.9 | 5.8 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
1.8 | 7.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.7 | 11.9 | GO:0033590 | response to cobalamin(GO:0033590) |
1.7 | 8.5 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
1.7 | 5.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.7 | 8.3 | GO:1904141 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
1.6 | 4.9 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.6 | 6.4 | GO:0003409 | optic cup structural organization(GO:0003409) |
1.6 | 9.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.6 | 4.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.5 | 1.5 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
1.5 | 7.5 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
1.5 | 4.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
1.4 | 7.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
1.4 | 1.4 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
1.4 | 9.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.4 | 5.6 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
1.4 | 5.6 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.3 | 4.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.3 | 5.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.3 | 13.8 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.3 | 3.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
1.3 | 6.3 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
1.2 | 3.7 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
1.2 | 6.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.2 | 4.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.2 | 3.5 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
1.2 | 8.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.1 | 3.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
1.1 | 4.6 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
1.1 | 4.5 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) |
1.1 | 4.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
1.1 | 1.1 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
1.1 | 8.8 | GO:0030578 | PML body organization(GO:0030578) |
1.1 | 7.6 | GO:0001554 | luteolysis(GO:0001554) |
1.1 | 2.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
1.1 | 1.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.1 | 7.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
1.1 | 9.5 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.0 | 4.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.0 | 8.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.0 | 6.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.0 | 4.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.0 | 3.0 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.0 | 3.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.0 | 3.0 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
1.0 | 3.0 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.0 | 2.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
1.0 | 2.9 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.0 | 9.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
1.0 | 2.9 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.9 | 8.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.9 | 0.9 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.9 | 5.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.9 | 5.5 | GO:0014028 | notochord formation(GO:0014028) |
0.9 | 4.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.9 | 3.6 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.9 | 3.5 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.9 | 2.6 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.9 | 2.6 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.9 | 2.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.9 | 3.4 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.8 | 3.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.8 | 2.4 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.8 | 1.6 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.8 | 2.4 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.8 | 3.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.8 | 7.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.8 | 2.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.8 | 1.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 1.5 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.8 | 3.8 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.8 | 3.0 | GO:0071505 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.8 | 3.8 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.7 | 2.2 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.7 | 5.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.7 | 2.2 | GO:1904799 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.7 | 3.6 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.7 | 2.1 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.7 | 9.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.7 | 2.8 | GO:2000685 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.7 | 1.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.7 | 4.2 | GO:0021764 | amygdala development(GO:0021764) |
0.7 | 3.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.7 | 3.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.7 | 5.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.7 | 0.7 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.7 | 2.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.7 | 4.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 6.0 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.7 | 2.7 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
0.7 | 0.7 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.7 | 2.0 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.7 | 4.6 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.7 | 2.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.7 | 2.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.7 | 7.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.6 | 18.2 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.6 | 5.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.6 | 0.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 1.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.6 | 1.9 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.6 | 0.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.6 | 5.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.6 | 2.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.6 | 1.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.6 | 2.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.6 | 3.7 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.6 | 2.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.6 | 1.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.6 | 0.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.6 | 1.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.6 | 4.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.6 | 1.8 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.6 | 1.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 3.0 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.6 | 26.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 4.1 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.6 | 4.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.6 | 3.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 1.8 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.6 | 3.5 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.6 | 7.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 1.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.6 | 1.7 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.6 | 2.3 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.6 | 8.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.6 | 1.7 | GO:1902941 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
0.6 | 1.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.5 | 3.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 1.6 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.5 | 1.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.5 | 0.5 | GO:0070305 | response to cGMP(GO:0070305) |
0.5 | 3.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.5 | 4.3 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.5 | 1.6 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.5 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 1.6 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.5 | 1.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 1.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.5 | 1.0 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.5 | 5.7 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 3.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.5 | 1.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 0.5 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.5 | 2.1 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.5 | 0.5 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.5 | 2.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 0.5 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.5 | 2.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.5 | 1.5 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.5 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 2.5 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.5 | 1.0 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.5 | 2.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.5 | 3.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.5 | 0.5 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.5 | 1.5 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.5 | 1.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.5 | 4.4 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.5 | 2.0 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.5 | 2.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 15.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.5 | 4.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.5 | 2.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.5 | 1.5 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.5 | 3.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.5 | 1.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.5 | 1.9 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.5 | 1.4 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.5 | 3.3 | GO:2000769 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.5 | 1.4 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.5 | 2.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.5 | 0.5 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.5 | 1.4 | GO:1900368 | pre-miRNA export from nucleus(GO:0035281) regulation of RNA interference(GO:1900368) |
0.5 | 2.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.5 | 1.4 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.5 | 1.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.5 | 7.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 2.8 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.5 | 3.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 2.7 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.5 | 0.9 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.5 | 2.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 1.4 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.5 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.5 | 1.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.5 | 2.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 1.8 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.4 | 3.6 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.4 | 2.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 0.4 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
0.4 | 0.4 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.4 | 1.8 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.4 | 3.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 5.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 2.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 0.4 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.4 | 1.3 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.4 | 0.4 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.4 | 0.4 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.4 | 4.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.4 | 1.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 1.3 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.4 | 2.1 | GO:1990834 | response to odorant(GO:1990834) |
0.4 | 2.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 1.7 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.4 | 2.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 0.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.4 | 1.3 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.4 | 2.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.4 | 1.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 1.7 | GO:0033504 | floor plate development(GO:0033504) |
0.4 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.4 | 1.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 4.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 1.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.4 | 1.2 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.4 | 1.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.4 | 6.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 0.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.4 | 5.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 2.8 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.4 | 4.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.4 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 1.2 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 3.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.4 | 0.8 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 1.6 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.4 | 1.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.4 | 2.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 1.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.4 | 0.4 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 1.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 1.2 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.4 | 1.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.4 | 0.4 | GO:1902908 | regulation of melanosome transport(GO:1902908) regulation of melanosome organization(GO:1903056) |
0.4 | 1.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.4 | 6.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.4 | 1.1 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.4 | 0.4 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.4 | 1.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 5.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 1.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.4 | 0.4 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.4 | 2.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 2.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.5 | GO:1904647 | response to rotenone(GO:1904647) |
0.4 | 0.7 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.4 | 1.8 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.4 | 1.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 3.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 1.1 | GO:1904529 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.4 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 1.8 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.4 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.4 | 1.5 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.4 | 1.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 3.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.4 | 2.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 1.8 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 0.7 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
0.3 | 0.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 1.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 1.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 1.0 | GO:0044691 | tooth eruption(GO:0044691) |
0.3 | 6.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 1.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.3 | 1.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.3 | 1.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 2.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.3 | 0.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.3 | 0.3 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.3 | 2.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 1.4 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.3 | 1.0 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 6.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 1.0 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.3 | 1.7 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.3 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.3 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.3 | 2.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 0.7 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.3 | 1.0 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.3 | 2.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 0.3 | GO:0051595 | response to methylglyoxal(GO:0051595) |
0.3 | 0.3 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.3 | 1.0 | GO:0090346 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.3 | 0.7 | GO:1901355 | response to rapamycin(GO:1901355) |
0.3 | 1.3 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
0.3 | 1.0 | GO:0015840 | urea transport(GO:0015840) |
0.3 | 1.0 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.3 | 3.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 1.0 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.3 | 0.6 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.3 | 1.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.3 | 0.6 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.3 | 0.6 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.3 | 2.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 1.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 0.6 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.3 | 1.9 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.3 | 0.9 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.3 | 7.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 2.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 1.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.3 | 1.3 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.3 | 1.6 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.3 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.3 | 0.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 1.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.3 | 1.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 1.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 2.4 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.3 | 1.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.3 | 0.9 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.3 | 1.2 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.3 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.3 | 1.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.6 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.3 | 1.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 0.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.3 | 2.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 7.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 0.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 0.9 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.3 | 1.5 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
0.3 | 0.6 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.3 | 3.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.3 | 1.5 | GO:0060356 | leucine import(GO:0060356) |
0.3 | 2.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.2 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 1.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.3 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.3 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 2.3 | GO:0043622 | cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
0.3 | 1.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 35.9 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 2.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 0.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.3 | 2.3 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.3 | 1.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 0.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 1.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.3 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 9.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 2.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.9 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 0.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.3 | 2.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.3 | 2.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.3 | 0.3 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.3 | 0.3 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) |
0.3 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 0.3 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.3 | 1.1 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
0.3 | 0.8 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.3 | 3.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 0.8 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.3 | 1.9 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.1 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.3 | 1.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 5.2 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.5 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 0.8 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.3 | 2.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 4.7 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.3 | 1.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.3 | 2.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
0.3 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 0.5 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 3.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.3 | 0.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 2.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 0.8 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
0.3 | 1.1 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.3 | 1.1 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.3 | 0.5 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.3 | 3.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.3 | 0.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 1.1 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.3 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.3 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 2.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 6.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 1.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.3 | 1.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.3 | 1.3 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.3 | 0.8 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.3 | 0.8 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.3 | 1.0 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.3 | 0.5 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 1.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.3 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 3.4 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.3 | 0.5 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.3 | 1.0 | GO:0042335 | cuticle development(GO:0042335) |
0.3 | 2.8 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.3 | 0.5 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.3 | 0.3 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.3 | 0.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.3 | 2.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 1.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 1.5 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 1.0 | GO:0019046 | release from viral latency(GO:0019046) |
0.3 | 0.8 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.3 | 0.8 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.3 | 0.5 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.2 | 2.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 2.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.5 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 2.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 2.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 3.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.2 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.2 | 1.7 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.2 | 3.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 2.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 1.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
0.2 | 1.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 2.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.7 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.2 | 0.5 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.2 | 1.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 3.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 1.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 3.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.2 | 0.7 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.2 | 0.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 2.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 2.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.2 | 2.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 2.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 6.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.2 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.2 | 1.1 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.2 | 0.5 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 0.9 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 1.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.2 | 3.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.5 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.2 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.5 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.2 | 1.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 0.7 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.2 | 2.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.7 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.2 | 0.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.2 | 1.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.7 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 1.8 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 1.6 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.7 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.2 | 3.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 2.4 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 1.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 1.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.2 | 1.8 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.2 | 1.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 1.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 2.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 4.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 1.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 1.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 1.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 1.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 1.3 | GO:0035624 | receptor transactivation(GO:0035624) |
0.2 | 0.6 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.2 | 2.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.2 | 0.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 1.0 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.2 | 0.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.2 | 0.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.2 | 3.3 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.2 | 0.6 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.2 | 2.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 2.7 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 0.4 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.2 | 0.6 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.2 | 0.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.2 | 1.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 | 0.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 1.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 0.2 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.2 | 1.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 1.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 1.6 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.6 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.2 | 1.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 4.4 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.2 | 2.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.8 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.2 | 1.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 1.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 1.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.2 | 1.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 0.8 | GO:0036269 | swimming behavior(GO:0036269) |
0.2 | 0.4 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.2 | 3.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.8 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.2 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.6 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.2 | 0.8 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.2 | 0.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 3.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 2.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.6 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 1.7 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 1.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 2.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.9 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 0.2 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.2 | 0.6 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 1.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 1.1 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 1.9 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 1.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 0.2 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 0.7 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 1.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 1.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 2.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 0.6 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.2 | 0.7 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 2.4 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 5.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.2 | 0.5 | GO:0051414 | response to cortisol(GO:0051414) |
0.2 | 1.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 2.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.2 | 0.9 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.2 | 0.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 2.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.7 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.9 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.2 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.2 | 0.4 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.9 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.2 | 6.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 1.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.2 | 1.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 0.4 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 0.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.2 | 3.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.2 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 0.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.5 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.2 | 0.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 0.7 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 0.7 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 1.9 | GO:0048308 | organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
0.2 | 1.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.7 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.2 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.5 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.2 | 0.9 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.2 | 1.7 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.3 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 0.2 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.2 | 1.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 2.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.8 | GO:0061056 | sclerotome development(GO:0061056) |
0.2 | 0.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.2 | 0.3 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.2 | 1.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.3 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.2 | 0.5 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.2 | 1.0 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.2 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.2 | 7.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 1.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 5.8 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.2 | 0.3 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.8 | GO:1903412 | response to bile acid(GO:1903412) |
0.2 | 0.5 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 1.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 1.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.2 | 3.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 1.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 0.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.3 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.2 | 0.6 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.2 | 0.3 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 0.5 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 1.6 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.2 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.5 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 1.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 1.0 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 0.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.2 | 0.3 | GO:0048241 | epinephrine transport(GO:0048241) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.4 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.8 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 1.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.2 | 2.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.2 | 0.5 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.2 | 0.6 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.2 | 1.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 1.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 1.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.9 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 1.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.3 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.2 | 0.5 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.2 | 2.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 2.3 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.2 | 2.4 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.2 | 0.8 | GO:0015692 | lead ion transport(GO:0015692) |
0.2 | 3.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 0.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 4.4 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 0.8 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.6 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 14.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.6 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.9 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 5.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.3 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.1 | 0.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.6 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.1 | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.1 | 0.6 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.1 | 3.0 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.1 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 1.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.1 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.1 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.4 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 1.3 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.8 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.7 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 0.6 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 3.2 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 1.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.4 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 1.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 2.6 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.9 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 0.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 1.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.7 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.9 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.5 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.1 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.3 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.1 | 0.5 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 1.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.4 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.1 | 0.4 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 1.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.3 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.1 | 4.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.6 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 1.0 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.4 | GO:0045575 | basophil activation(GO:0045575) |
0.1 | 1.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.4 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.1 | 0.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 1.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.5 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 0.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 0.2 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 1.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.7 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.7 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 2.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.6 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.1 | 1.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.2 | GO:1902739 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 1.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 1.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 1.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.1 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.3 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.1 | 0.2 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.1 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 1.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.8 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 1.7 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.3 | GO:0071529 | cementum mineralization(GO:0071529) |
0.1 | 0.3 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.3 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.1 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) |
0.1 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 1.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.3 | GO:1904247 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.1 | 1.1 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:0070922 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) small RNA loading onto RISC(GO:0070922) |
0.1 | 2.4 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 1.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 4.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.3 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.2 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.1 | 0.4 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.1 | 0.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.1 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.5 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 4.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:0018201 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.1 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 1.8 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.1 | 0.8 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 1.2 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 0.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.1 | 0.3 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 1.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 1.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 1.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.6 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.5 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 6.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.5 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.3 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.1 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.1 | 0.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.5 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.1 | 1.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 1.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.6 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.4 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 1.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.1 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.2 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.1 | 0.6 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.5 | GO:0007628 | adult walking behavior(GO:0007628) |
0.1 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.2 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.1 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.9 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 3.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 1.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.3 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 0.2 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.1 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.6 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.1 | 0.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.1 | 0.3 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.4 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 0.3 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.1 | 1.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.5 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 0.7 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.3 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.2 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.1 | 1.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.3 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.1 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.0 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) metanephric proximal tubule development(GO:0072237) |
0.1 | 0.2 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 0.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 4.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 6.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 1.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 4.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.1 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.4 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.4 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.6 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.6 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.7 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) somatotropin secreting cell development(GO:0060133) |
0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 2.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 1.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 2.7 | GO:0007004 | telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 1.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.1 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.1 | 2.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.3 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 1.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 1.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.4 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.8 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 0.4 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.6 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 | 3.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
0.1 | 0.2 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) positive regulation of estrogen secretion(GO:2000863) regulation of estradiol secretion(GO:2000864) positive regulation of estradiol secretion(GO:2000866) |
0.1 | 1.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 7.8 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 1.0 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 0.2 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.4 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 1.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.2 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 | 0.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 0.2 | GO:0015942 | formate metabolic process(GO:0015942) |
0.1 | 0.2 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.2 | GO:1900193 | negative regulation of oocyte development(GO:0060283) regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.8 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 2.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 1.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.2 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.1 | 0.3 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.6 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 | 1.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.4 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.1 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.1 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.1 | 0.1 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
0.1 | 0.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.1 | 0.2 | GO:0051985 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of chromosome segregation(GO:0051985) |
0.1 | 0.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) development involved in symbiotic interaction(GO:0044111) |
0.1 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.8 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.8 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.4 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 2.1 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.1 | 2.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 1.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.2 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.1 | 1.4 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.1 | 1.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.0 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 2.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 1.2 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.0 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.2 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 2.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.2 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.0 | 0.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 1.8 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 4.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.0 | 0.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.2 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 3.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.1 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.1 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.2 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.3 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 2.2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 1.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0035803 | egg coat formation(GO:0035803) |
0.0 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.0 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.0 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 1.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.0 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.0 | 0.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.0 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.8 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.5 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.0 | 0.3 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 0.3 | GO:1901070 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.1 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.2 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.0 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.0 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.0 | 1.7 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) maintenance of ER location(GO:0051685) |
0.0 | 0.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.3 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.0 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.7 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 0.1 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 1.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.6 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 0.1 | GO:0019563 | glycerol catabolic process(GO:0019563) |
0.0 | 0.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 1.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.0 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 1.5 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.0 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.0 | 0.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.0 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.0 | 0.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.0 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 19.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
2.6 | 18.4 | GO:0042825 | TAP complex(GO:0042825) |
2.5 | 7.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
2.2 | 6.5 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
2.0 | 18.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.9 | 15.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
1.4 | 8.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
1.4 | 5.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
1.3 | 10.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.2 | 3.7 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
1.1 | 1.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.9 | 7.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.9 | 5.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.8 | 9.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 0.8 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.8 | 2.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.7 | 2.8 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.7 | 0.7 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.7 | 8.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 4.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.7 | 7.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 4.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 3.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.6 | 7.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 0.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 12.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 2.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.5 | 2.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 6.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 3.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.5 | 1.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 1.4 | GO:0044753 | amphisome(GO:0044753) |
0.5 | 1.4 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.5 | 1.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 36.0 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 0.9 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.4 | 1.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 1.8 | GO:0045160 | myosin I complex(GO:0045160) |
0.4 | 9.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 8.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 1.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.4 | 4.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 2.0 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 5.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 2.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 2.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 1.2 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 5.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 1.6 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.4 | 0.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 5.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.4 | 2.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 0.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 1.5 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.4 | 1.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 1.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 3.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 1.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 2.9 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 1.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 1.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.3 | 1.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 14.2 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 2.8 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.3 | 6.5 | GO:0032059 | bleb(GO:0032059) |
0.3 | 2.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 1.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.3 | 3.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.0 | GO:1990742 | microvesicle(GO:1990742) |
0.3 | 2.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 1.0 | GO:0018444 | translation release factor complex(GO:0018444) |
0.3 | 0.3 | GO:0033643 | host cell part(GO:0033643) host intracellular part(GO:0033646) host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) intracellular region of host(GO:0043656) |
0.3 | 3.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 2.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.3 | 1.3 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.3 | 2.5 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.3 | 1.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.3 | 2.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 1.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 3.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 5.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 1.5 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 2.0 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.3 | 2.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 2.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.3 | 2.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.4 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 1.6 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.3 | 0.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 0.3 | GO:0044301 | climbing fiber(GO:0044301) |
0.3 | 0.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.3 | 0.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 2.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 0.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.3 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 5.9 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 5.9 | GO:0001741 | XY body(GO:0001741) |
0.3 | 0.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 1.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 6.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 6.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 8.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.0 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 2.1 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.7 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 0.9 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.8 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 3.3 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.2 | 1.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 3.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 0.9 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.6 | GO:0044609 | DBIRD complex(GO:0044609) |
0.2 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.8 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 1.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 0.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 1.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 5.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 1.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 3.0 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.2 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.0 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.2 | 3.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.6 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 3.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.3 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 0.6 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.2 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.5 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.2 | 1.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 4.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 6.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 1.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.5 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 3.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 5.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 3.9 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 4.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 2.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.2 | 2.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.7 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 3.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 0.8 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.2 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.6 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 5.7 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 3.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 17.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.5 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 2.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.2 | 5.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.8 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 8.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 4.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.6 | GO:0032044 | DSIF complex(GO:0032044) |
0.2 | 0.8 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 0.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 2.1 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 2.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 1.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 2.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 7.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.0 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 0.4 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.1 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 18.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.4 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 1.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 3.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 3.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 1.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 1.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 3.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 5.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 2.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 0.7 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 5.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 1.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 18.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 2.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.6 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 2.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.9 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 2.0 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.3 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 1.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 6.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 4.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 1.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 10.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 1.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.7 | GO:0048500 | signal recognition particle(GO:0048500) |
0.1 | 0.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 2.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.7 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
0.1 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.9 | GO:0000801 | central element(GO:0000801) |
0.1 | 3.4 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.1 | 0.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 2.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.8 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.3 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 14.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 5.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.9 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 4.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 2.0 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 8.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 7.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 5.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 1.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.7 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 9.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 6.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 0.2 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.1 | 8.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 1.2 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 4.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 1.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 5.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.2 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 1.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.6 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.0 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 31.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 1.4 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 4.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 2.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 3.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.6 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 68.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.1 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.0 | 4.5 | GO:0098857 | membrane microdomain(GO:0098857) |
0.0 | 56.8 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.0 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.4 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.0 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 5.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.0 | 1.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.0 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.9 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.0 | GO:0034455 | t-UTP complex(GO:0034455) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.7 | 32.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
4.9 | 19.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.0 | 21.0 | GO:0046979 | TAP2 binding(GO:0046979) |
3.0 | 8.9 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
2.7 | 8.0 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
2.2 | 9.0 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
1.4 | 5.8 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
1.4 | 22.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.4 | 4.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.3 | 4.0 | GO:0098808 | mRNA cap binding(GO:0098808) |
1.3 | 3.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.3 | 6.3 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
1.2 | 6.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 9.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.2 | 9.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.1 | 5.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
1.1 | 4.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.1 | 6.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.0 | 9.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.0 | 3.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.0 | 2.0 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
1.0 | 2.0 | GO:0030305 | heparanase activity(GO:0030305) |
1.0 | 4.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.9 | 3.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.9 | 5.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.8 | 2.4 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.8 | 2.4 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.8 | 4.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.8 | 3.9 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.8 | 3.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 2.2 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.7 | 2.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.7 | 2.1 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.7 | 4.3 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.7 | 5.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 2.8 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.7 | 0.7 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.7 | 2.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.7 | 4.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.7 | 3.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.7 | 7.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.7 | 4.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 3.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.6 | 12.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.6 | 1.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.6 | 6.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 2.5 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.6 | 19.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.6 | 8.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 2.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.6 | 2.9 | GO:0048030 | disaccharide binding(GO:0048030) |
0.6 | 2.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 1.7 | GO:0070984 | SET domain binding(GO:0070984) |
0.6 | 5.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 2.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.6 | 3.4 | GO:0042835 | BRE binding(GO:0042835) |
0.6 | 2.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.6 | 5.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.6 | 3.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 1.7 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.6 | 3.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.6 | 2.2 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.6 | 3.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 1.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.5 | 3.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 7.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 2.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.5 | 2.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 5.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 2.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.5 | 1.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.5 | 1.6 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.5 | 4.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 1.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 4.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.5 | 2.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 13.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.5 | 2.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 3.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 2.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.5 | 2.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.5 | 3.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.5 | 1.9 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.5 | 1.9 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.5 | 1.4 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.5 | 2.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.5 | 1.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.5 | 8.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 2.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 3.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.5 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 3.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 4.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.4 | 6.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 1.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.4 | 2.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.4 | 1.3 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.4 | 2.2 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 2.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 0.9 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.4 | 20.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 2.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 13.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 4.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 3.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 4.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 1.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 1.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 0.4 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.4 | 4.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.4 | 4.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.4 | 2.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.4 | 1.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 2.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 1.2 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.4 | 3.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 1.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.4 | 1.1 | GO:0005497 | androgen binding(GO:0005497) |
0.4 | 10.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.4 | 3.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 3.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 3.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.5 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.4 | 1.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 6.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 1.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 6.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 2.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 2.5 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.4 | 1.8 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.4 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 1.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.4 | 1.4 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.4 | 1.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.3 | 0.7 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.3 | 1.4 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.3 | 1.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 1.0 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.3 | 4.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 8.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 2.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 1.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 10.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.0 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.3 | 4.0 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 0.7 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.3 | 1.0 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.3 | 0.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 2.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 1.0 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.3 | 6.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 2.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 2.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.3 | 1.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.3 | 0.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.3 | 15.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 4.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 0.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 0.3 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.3 | 2.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 2.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 0.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 0.6 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 1.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.7 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.3 | 4.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 1.7 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.3 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 0.8 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.3 | 11.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.3 | 3.1 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 1.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.3 | 1.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 1.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 3.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 2.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 2.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 4.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 1.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 2.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 3.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 0.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 4.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 1.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 5.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.3 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 4.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 2.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 2.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 1.3 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.3 | 0.8 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.3 | 5.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 1.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.3 | 2.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 4.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 0.8 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.2 | 1.2 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 3.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 2.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 0.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 2.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 2.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 3.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 2.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.2 | 0.7 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.2 | 3.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 0.7 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
0.2 | 1.0 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 4.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 10.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 1.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 13.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.7 | GO:0033677 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.2 | 0.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.2 | 5.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 1.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 2.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 1.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 3.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 5.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 5.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 3.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 7.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 3.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 1.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 1.5 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 2.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 2.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.6 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.2 | 6.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 3.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.2 | 4.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 2.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 3.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 30.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 1.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 22.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.2 | 2.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.6 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.2 | 0.2 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.2 | 1.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.6 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.2 | 0.8 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.2 | 5.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 2.0 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.2 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 3.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.8 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.6 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 0.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.2 | 0.6 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 3.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 3.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 1.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.8 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.2 | 0.6 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.2 | 1.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.6 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.2 | 0.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 1.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 1.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.6 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 0.5 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.2 | 1.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.2 | 2.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 1.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 4.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 3.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 1.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 9.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.7 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 2.7 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 0.5 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.2 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 3.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 1.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 3.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 2.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 2.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 1.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.2 | 2.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.5 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.2 | 6.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.8 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.2 | 4.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 1.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.2 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.2 | 4.4 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 2.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 2.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.5 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.2 | 1.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 2.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.6 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.2 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.8 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.9 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 0.7 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 1.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 1.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.1 | 0.7 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.1 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 3.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 1.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 2.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 2.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.1 | 0.4 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.1 | 4.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.4 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.1 | 1.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.9 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 4.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 4.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 2.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 4.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.3 | GO:0004938 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.4 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 7.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 10.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.7 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 2.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 2.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 5.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.5 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.4 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.1 | 0.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.1 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 4.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 5.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 3.4 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.8 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.1 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.6 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 2.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 3.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 4.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 3.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.3 | GO:0004040 | amidase activity(GO:0004040) |
0.1 | 1.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 2.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 3.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 5.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.2 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 1.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 2.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) |
0.1 | 7.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 2.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 2.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.1 | 0.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 2.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 1.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 2.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 3.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.3 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 1.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 2.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.5 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 1.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 2.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.2 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 1.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.2 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.1 | 0.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 1.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 2.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.3 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 22.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 1.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.9 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 2.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 12.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 2.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 2.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 6.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.1 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.1 | 0.3 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 2.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.3 | GO:0032406 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 4.4 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.8 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.1 | GO:0001032 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.1 | 0.2 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.4 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 2.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.5 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 1.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.1 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 3.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.0 | 1.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.2 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.1 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 0.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 4.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 1.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.7 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 13.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 2.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 2.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 1.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.0 | 0.0 | GO:0032427 | GBD domain binding(GO:0032427) |
0.0 | 0.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 1.6 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.0 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 2.3 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 1.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 1.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 9.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 1.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 1.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.0 | 2.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.0 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.0 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 1.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.7 | 28.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.7 | 2.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 19.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 16.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 5.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 14.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 13.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 24.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.4 | 27.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 6.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 9.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 2.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 3.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 1.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 0.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 25.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 1.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 1.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 4.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 5.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 13.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 8.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 3.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 10.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 2.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 4.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 5.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 2.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 14.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 8.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 10.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 9.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 1.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 1.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 16.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 5.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 7.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 5.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 9.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 1.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 65.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 1.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 6.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 9.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 1.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 13.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 3.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 3.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 4.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 4.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 24.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 29.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 3.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 4.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 2.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 3.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 3.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 2.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 5.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 1.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 25.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.0 | 10.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 49.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 16.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 16.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 10.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 1.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 8.8 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 13.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 10.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 5.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.4 | 4.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 17.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 0.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.4 | 32.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 19.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 0.7 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 23.8 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.3 | 1.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 7.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 12.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 7.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 14.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 4.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 2.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 15.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.3 | 7.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 5.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 7.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 3.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 7.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 5.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 5.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 4.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 6.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 10.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 4.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.3 | 15.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 3.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 5.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 7.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 0.9 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.2 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 3.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 11.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 11.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 7.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 3.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 9.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 14.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 13.0 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 5.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 10.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 3.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 9.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 4.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 2.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.7 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.2 | 3.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 3.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 3.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 5.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.3 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.2 | 0.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 4.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 4.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 3.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 2.7 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 3.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 8.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 10.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 6.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 4.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 6.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 5.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 4.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.9 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 14.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 2.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 5.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 2.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 2.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 6.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 1.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 5.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.4 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 3.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 5.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.7 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 1.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 4.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 7.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 1.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 1.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 1.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.0 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 3.0 | REACTOME AXON GUIDANCE | Genes involved in Axon guidance |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |